Save interesting pages while you browse the DKSH website via the button on the bottom of the page. You will find the pages you saved in this area again.
Need to collect information around a topic? Just save relevant download documents here. You can save them later or send a list via email. You will find the option for all documents offered for download.
Please note: This information is saved in a cookie. In case your browser deletes cookies after a session, the information will be lost.
DKSH results reach record levels in 2016 – an increase in all key figures despite challenging markets
• Net sales grow in 2016 by 4.5% to CHF 10.5 billion • Operating profit (EBIT) increases over-proportionally by 8.4% to CHF 293.0 million • Profit after tax of CHF 213.0 million significantly above last year • Proposal to increase ordinary dividend by 15.4% to CHF 1.50 per share • Additional special dividend of CHF 3.00 per share proposed • Further net sales and profit growth expected
DKSH acquires medical device distributor in Cambodia
Zurich, Switzerland, January 24, 2017 – DKSH, the leading Market Expansion Services provider with a focus on Asia, today announced the acquisition of Europ Continents Cambodia, a major provider of medical devices, in vitro diagnostic and laboratory products in Cambodia. As one of the fastest-growing companies in Cambodia, DKSH further strengthens its leading position in the healthcare sector with this transaction and drives forward the consolidation of the Market Expansion Services industry in Asia.
Roland Berger future study confirms attractiveness of Market Expansion Services in Asia
Zurich, Switzerland, January 17, 2017 – The continued positive growth dynamics in the Asian markets offer promising development opportunities for companies. With an average annual growth rate of 6.5% over the next five years, the future outlook of Market Expansion Services in Asia remains prosperous as shown by the new study from Roland Berger.